Reports from the Field — Neurology
Reports from the Field — Neurology
One-stop MS information
A new web site features extensive information about multiple sclerosis and encourages early diagnosis and treatment. Launched in June by Accel Healthcare Communications, Multiplesclerosis.com is geared to people with MS, their families, friends, and health care providers.
The site includes breaking news; articles from scientific and medical journals; signs, symptoms, and diagnostic tests; and treatment options, including alternative and experimental therapies. The web site also has tips on living with the disease, monitoring disease progression, managing and preventing treatment side effects, and complying with therapy. The section for professionals covers practice guidelines, medical conference highlights, resources, an advanced literature search engine, links to other web sites, and recommended reading.
Alzheimer’s drug may help vascular dementia
Patients with dementia caused by cerebrovascular disease, such as stroke, may benefit from a drug that has been approved for patients with mild-to-moderate Alzheimer’s disease. A six-month study presented at the World Congress of Neurology shows that Reminyl (galantamine hydrobromide) maintains memory, orientation, and language skills for a year in patients with both dementia and cerebrovascular disease.
"If the findings of this study are replicated through further research, physicians can be more confident about treating dementia in individuals in whom vascular damage has occurred," says Roger Bullock, MD, of the Kinghill Research Centre in Swindon, United Kingdom.
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.